Culanag Jr, Francisco T.

HRN: 23-06-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2023
CEFTRIAXONE 1G (VIAL)
08/12/2023
08/18/2023
IV
2gm
Q24
Acalculous Cholecystitis
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: